During a health pandemic, should vaccine patents be allowed or should there be some sort of exception?

PatentsIP Litigation
Written By Klemchuk LLP

As the potential for a COVID-19 vaccine appears to be on the horizon, worries about vaccine patents and expensive licenses have health and legal experts voicing concerns because, without proper oversight:

  • vaccines may be too expensive to distribute to those who need it;

  • major conflicts may arise between countries that have licenses and those that do not; and

  • patent disputes may cause the vaccine distribution to be tied up during litigation.

Read about how The Thought of COVID-19 Vaccine Patents Are Causing Health and Legal Concerns.

———

This blog is published by Klemchuk LLP, a litigation, intellectual property, transactional, and international business law firm dedicated to protecting innovation. The firm provides tailored legal solutions to industries including software, technology, retail, real estate, consumer goods, ecommerce, telecommunications, restaurant, energy, media, and professional services.

Klemchuk LLP

This blog is published by Klemchuk LLP, a litigation, intellectual property, transactional, and international business law firm dedicated to protecting innovation. The firm provides tailored legal solutions to industries including software, technology, retail, real estate, consumer goods, ecommerce, telecommunications, restaurant, energy, media, and professional services.

The firm publishes Ideate, a blog discussing the latest news and insights into intellectual property law, business, and culture.

Previous

How would a federal privacy law help with data collection and protection of personal data?

Next

What HIPAA Privacy Rights Should Employers Be Aware of As Employees Return to Work after Lockdown?